Showing results (11-20 of 508) with videos related to
Sort By:
Pageof 51
Cardiology|January 25, 2014
p2y12 receptor inhibitors in acute coronary syndromes: from the research laboratory to the clinic and vice versaDimitrios AlexopoulosExpert Review of Hematology|September 21, 2012
Prediction of clopidogrel efficacy and safety: phenotyping and/or genotyping?Dimitrios AlexopoulosInternational Journal of Cardiology|July 10, 2010
Clopidogrel pretreatment in PCI: absolute requirement or obsolete myth?Dimitrios AlexopoulosInternational Journal of Cardiology|December 24, 2011
P2Y12 inhibitors adjunctive to primary PCI therapy in STEMI: fighting against the activated plateletsDimitrios AlexopoulosCardiovascular Therapeutics|May 2, 2017
Gender-related differences in antiplatelet treatment patterns and outcome: Insights from the GReekAntiPlatElet RegistryIoanna Xanthopoulou, Periklis Davlouros, Spyridon Deftereos, et al.International Journal of Cardiology|April 19, 2015
A predictive score of radial artery spasm in patients undergoing transradial percutaneous coronary interventionGeorgios Giannopoulos, Konstantinos Raisakis, Andreas Synetos, et al.Thrombosis Research|October 10, 2013
Use of antiplatelet agents in sepsis: a glimpse into the futureKarolina Akinosoglou, Dimitrios AlexopoulosClinical Cardiology|September 21, 2011
Long-term outcome of percutaneous coronary intervention: the significance of native coronary artery disease progressionAthanasios Moulias, Dimitrios AlexopoulosThrombosis Research|March 4, 2019
Antithrombotic treatment in atrial fibrillation patients undergoing PCI: Is dual therapy the winner?Christos Mantis, Dimitrios AlexopoulosPageof 51